CITIGROUP INC - MONTE ROSA THERAPEUTICS INC ownership

MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 54 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of MONTE ROSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,387
-95.5%
707
-93.6%
0.00%
Q2 2023$75,199
+829.1%
10,978
+956.6%
0.00%
Q1 2023$8,094
-20.6%
1,039
-22.5%
0.00%
Q4 2022$10,197
-15.0%
1,340
-11.3%
0.00%
Q3 2022$12,000
-61.3%
1,510
-52.6%
0.00%
Q2 2022$31,000
-11.4%
3,185
+27.7%
0.00%
Q1 2022$35,000
-64.3%
2,495
-48.1%
0.00%
Q4 2021$98,000
+237.9%
4,803
+263.6%
0.00%
Q3 2021$29,0001,3210.00%
Other shareholders
MONTE ROSA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,472,331$11,469,4585.52%
NEA Management Company, LLC 7,692,298$59,923,0014.14%
Cormorant Asset Management, LP 2,893,717$22,5421.48%
Alphabet Inc. 1,464,015$11,404,6770.63%
Avoro Capital Advisors LLC 4,325,000$33,691,7500.50%
Casdin Capital, LLC 510,882$3,979,7710.33%
SILVERARC CAPITAL MANAGEMENT, LLC 31,156$242,7050.10%
CORNERCAP INVESTMENT COUNSEL INC 28,192$219,6160.04%
UBS OCONNOR LLC 95,528$744,1630.02%
ExodusPoint Capital Management, LP 261,593$2,0380.02%
View complete list of MONTE ROSA THERAPEUTICS INC shareholders